NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 1.170
-0.030 (-2.50%)
Last updated: Oct 23, 2026, 8:01 AM CEST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €141.91 million as of October 26, 2026. Its market cap has decreased by 70.34% in one year.
Market Cap
141.91M
Enterprise Value
-24.53M
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 141.91M, an increase of 14.03%. That is a compound annual growth rate of 1.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 141.91M | -63.69% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Stratec SE | 285.66M |
| MEDICLIN Aktiengesellschaft | 249.38M |
| Medios AG | 248.00M |
| LIMES Schlosskliniken AG | 156.42M |